Literature DB >> 19651317

Adalimumab for Mooren's ulcer.

Miguel Cordero-Coma, Manuel Franco Benito, Carlos Lobato Fuertes, Sara Calleja Antolín, José M García Ruíz.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19651317     DOI： 10.1016/j.ophtha.2009.03.019

Source DB:  PubMed          Journal:  Ophthalmology        ISSN： 0161-6420            Impact factor:   12.079


× No keyword cloud information.
  2 in total

1.  Increased succinate receptor GPR91 involved in the pathogenesis of Mooren's ulcer.

Authors:  Lin Li; Yan-Ling Dong; Ting Liu; Dan Luo; Chao Wei; Wei-Yun Shi
Journal:  Int J Ophthalmol       Date:  2018-11-18       Impact factor: 1.779

2.  Adalimumab for refractory peripheral ulcerative keratitis.

Authors:  Miguel Cordero-Coma; Raquel Salazar Méndez; Alvaro Casado Blanco; Ana López Corral; Sara Calleja-Antolín; José M Ruiz de Morales
Journal:  J Ophthalmic Inflamm Infect       Date:  2012-05-16
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.